Air Liquide SA (0NWF)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 173.06 |
|---|---|
| 52-week range | 136.18 – 185.80 |
| Return, 1 month / 3 months | +6.3% / −2.0% |
| Return, 1 year / 3 years | +12.2% / +44.9% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 17.2% |
| Worst drawdown (1 year) | -10.7% |
| Average daily value traded | 32.51M EUR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Air Liquide is a French industrial gas company based in Paris. It produces gases such as oxygen, nitrogen, hydrogen and argon, and supplies them along with related equipment and services to customers in manufacturing, chemicals, energy, food and healthcare. Its healthcare arm provides medical gases and home care services to hospitals and patients. The company also builds and operates gas production plants and offers engineering and installation work for industrial clients around the world.
On this site Air Liquide SA appears as a stock on the London Exchange (UK), code 0NWF, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Air Liquide SA (0NWF) trades on the London Exchange in UK. It last closed at EUR 173.06 on 19 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 428 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.2% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.8% | ||
| From 52-week high | -4.2% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 4.3% | ||
| 12-month return, skipping the last month | 5.6% | ||
| Risk (lower is better) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 17.2% | ||
| Worst drawdown (1 year) | -10.7% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 32.51M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +6.3% |
| 3 months | −2.0% |
| 6 months | +4.3% |
| 1 year | +12.2% |
| 3 years | +44.9% |
| 5 years | +75.7% |
Signals
| 50-day / 200-day average | 169.03 / 162.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 3.7000 |
| 19 May 2025 | EUR 3.3000 |
| 20 May 2024 | EUR 3.2000 |
| 15 May 2023 | EUR 2.9500 |
| 16 May 2022 | EUR 2.9000 |
| 17 May 2021 | EUR 2.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.